Ontario reported 1,958 new COVID-19 cases and 43 more deaths as the number of hospitalized patients held roughly steady and active infections continued to decline.
Ontario reported 2,417 cases on Sunday and 2,359 on Saturday.
“Locally, there are 727 new cases in Toronto, 365 in Peel and 157 in York Region,” Health Minister Christine Elliott wrote on Twitter.
The seven-day average of daily cases fell from 2,460 to 2,371.
Provincial labs processed about 36,000 test specimens in the past 24 hours, generating a positivity rate of at least 5.4 per cent.
There have been 5,846 deaths and 227,494 recoveries from coronavirus infection since Jan. 25, 2020.
Another 23,620 active cases remain in Ontario, and that number is down approximately 2,000 in the past week.
Twenty-seven of the deaths reported on Monday involved residents of the long-term care system.
There were at least 1,425 patients receiving care in Ontario hospitals on Monday, according to local public health units and hospital networks, and the Critical Care Services of Ontario report from Sunday said there were 415 adult patients in intensive care across Ontario, along with one child.
ICU occupancy has held roughly steady for the past two weeks.
About 283 people were breathing with the help of a ventilator.
Michael Garron Hospital intensivist Dr. Michael Warner said that admissions to hospital appear to be stabilizing, but the situation could worsen dramatically because of the highly infectious B.1.1.7 variant from the United Kingdom.
“I think it is great that case numbers are coming down, we can’t dispute that, and ICU admissions are stable around 415 for the past week or so. I guess that is good but we can’t let our guard down. And we really have no idea how much B117 and other variants are circulating in Ontario or Canada,” he said.
On Sunday, officials in Simcoe-Muskoka said they detected what is likely to be Ontario’s 21st case of the B.1.1.7 variant, in a retail store worker who had contact with residents of a Bradford long-term care home.
“As long as planes keep on landing in Canada and as long as there is no mandatory quarantine, in some kind of federal facility the front door is still open and new variants can enter.”
Public Health Ontario is conducting a “point-prevalence study” of all positive samples collected on a given day last week to see how many cases of the UK variant are circulating in the community.
Elsewhere in the GTA, Durham Region reported 62 new cases, Hamilton reported 55 new cases, and Halton Region reported 54 new cases.
Meanwhile, supply restrictions continue to limit the number of additional COVID-19 vaccinations administered per day.
Elliott said about 6,000 more doses were administered on Sunday, bringing the total to about 292,000 injections to date.
First patient in Quebec gets approval from Health Canada for magic mushroom therapy
MONTREAL — When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away.
“Before the treatment, it’s like you’re sitting in your car. It’s summer. You have your windows down; you’re stuck in rush-hour traffic; it’s noisy …. It’s unpleasant,” said Hartle, who lives in Saskatchewan.
“Your favourite song is on the radio, but you can’t actually appreciate any of it because all of the other distractions are preventing you from even noticing that the radio is on. After a psilocybin treatment,(it’s like) you’re still in your car, in traffic, but you have the windows up; the air conditioning is on and it’s quiet. It’s just you and the music.”
Hartle, 54, is one of the very few Canadians to have received legal psychedelics psychotherapy for a mental health condition since Health Canada made it easier in January for health-care workers to access psilocybin — the hallucinogenic compound found in some mushrooms.
In Montreal, meanwhile, a pioneering clinic in the emerging field of psychedelic-assisted psychotherapy is about to become the first health-care facility in Quebec to legally treat depression with psilocybin.
“It’s a privilege to be able to accompany people in the exploration of their psychological distress and to offer something different than conventional treatment such as antidepressants,” Dr. Andrew Bui-Nguyen, of the Mindspace by Numinus clinic, said in a recent interview.
Bui-Nguyen said his clinic received Health Canada’s approval onMay 5 to care for a patient who had undergone several unsuccessful treatments for depression.
“There’s a rigorous screening procedure,” Bui-Nguyen said, adding that Quebec’s health insurance plan doesn’t cover the treatment. “We look at the diagnosis, the medical history, if there’s a risk of addiction, what treatments have already been tried …. There must have been a lot of treatments done beforehand so the application is solid.”
Health Canada on Jan. 5 restored its “Special Access Program” — abolished under former prime minister Stephen Harper in 2013 — allowing health-care experts to request access to restricted drugs that have not yet been authorized for sale in the country.
Before January, people could only access psychedelic-assisted psychotherapy through clinical trials or medical exemptions. Now, licensed experts can file applications on behalf of patients with mental health conditions such as post-traumatic stress disorder, depression and anxiety, but for whom conventional treatment has failed.
Health Canada says it has received 15 requests for the use of psilocybin or MDMA — a psychedelic drug with stimulant properties — since resuming the program.
In April, a clinic called Roots To Thrive, in Nanaimo, B.C., became the first health centre in Canada to offer a legal psilocybin group therapy program, in which Hartle took part.
“The therapy part has a capital T in this whole process,” Hartle said. “It isn’t just taking psychedelics. It’s just a tool in the process; the therapy is crucial to getting a good outcome.”
Psychedelic-assisted treatment, Bui-Nguyen explained, requires multiple therapy sessions before and after patients experience the drug. Patients will consume psilocybin while they are supervised by two psychotherapists and remain in the clinic-secured environment for up to six hours.
“It’s not miraculous,” Bui-Nguyen said. “You don’t take psilocybin and that’s it, a psychedelic trip and after the depression is cured — no! The patient has a lot of work to do. But it opens perspectives; it creates new paths in the brain that we aren’t used to taking. The patient then explores new roads to get out of depression.”
In the world’s largest study on psychedelics’ affect on the brain, released in March in the journal Science Advances, lead author Danilo Bzdok said psychedelic drugs might just be the next big thing to improve clinical care of major mental health conditions.
“There’s something like a renaissance, a reawakening of psychedelics,” Bzdok, associate professor with McGill University’s biomedical engineering department, said in a recent interview.
He said the evidence-based benefits are very promising. Patients, he said, say they have experienced up to six months of lasting effects after a single psychedelic-aided therapy session. They have also experienced a reduction of symptoms associated with mental health conditions, Bzdok said, adding that there were fewer side-effects compared to antidepressants.
Mindspace by Numinus CEO Payton Nyquvest said psychedelics have the potential to become a widespread treatment. As Health Canada continues to approve more requests, he hopes the recognition will make the treatment much more accessible.
“We haven’t seen significant innovation in mental health care in probably over 40 years,” Nyquvest said in a recent interview.
“We’re at a time where new and better treatments for mental health are needed now more than ever. No matter what you look at, depression, anxiety, and suicidality … these are all rates that continue to go up with no clear line in terms of how we’re going to address these massive societal issues. Psychedelics represent an opportunity to make a significant impact.”
Hartle’s own experience echoed those hopes. “The improvement in my mental health is so night and day that it would be difficult to say all of the things that it does for me,” he said.
“I still have cancer. I still have difficulty with what it physically does, but there are days when I don’t even think about it. What would you do to have a day where you just feel normal?”
This report by The Canadian Press was first published May 16, 2022.
This story was produced with the financial assistance of the Meta and Canadian Press News Fellowship.
Virginie Ann, The Canadian Press
MARS Wildlife Centre closes due to avian influenza – Squamish Chief
The MARS Wildlife Centre north of Courtenay is closing to the public temporarily after avian influenza was found this week in a small poultry flock in the Comox Valley.
As of Monday, the visitor centre and gift shop will not be accessible to visitors.
“Our commitment to the safety and well-being of our resident ambassador birds (eagles, owls and crows) and wildlife patients is our first priority, and we hope that this additional precautionary measure will help reduce the risk of on-site transmission of the virus,” Gyl Andersen, centre manager of wildlife rehabilitation, said in a statement.
The Mountainaire Avian Rescue Society worries that needed donations to operate the centre will drop during the time the centre it is closed, at a time of year when expenses rise.
Andersen is asking supporters to donate to its animal care fund.
It is “baby season” and the influx of injured and orphaned baby birds, raccoon kits, and other small mammals has begun, Andersen said.
The largest expenses at this time of year are food and nursery supplies. Also needed are personal protective equipment and cleaning supplies to combat viruses.
The Canadian Food Inspection agency confirmed Wednesday that Vancouver Island’s first case of the H5N1 virus was found in the small flock.
This is the first reported case on the Island, which may have been caused by infected migrating wild birds.
Increased bio-security measures have been put into place to protect birds at the centre, where its wildlife hospital remains open, Andersen said.
Sanitizing footbaths, a separate patient admission building, quarantine zones for different species, and covering the ambassador enclosures are among safety measures implemented.
Anyone bringing an injured animal to the Merville centre must remain in their vehicle and call the hospital at 250-337-2021, extension zero to speak to rehabilitation staff, who will come and collect the animal.
The centre said dead birds can not be brought to the centre. Call the centre for advice. The bird hotline can be called at 1-866-431-2473.
Rise of acute hepatitis among kids: Find out what is causing it, symptoms to note and all about the role of vaccines – Times of India
Besides the adenovirus 41, scientists continue to investigate COVID-19 as a potential underlying cause of the rise in recent cases of acute hepatitis in children.
An Indian study conducted by a team of researchers from the Bundelkhand Medical College (BMC), Sagar, Madhya Pradesh and the Post Graduate Institute of Medical Research, Chandigarh found that of 475 children, who tested positive for COVID-19 from April-July in 2021, 37 were diagnosed with COVID Acquired Hepatitis (CAH).
“We observed a peculiar rise in hepatitis cases. Usually, the beginning of monsoon marks a rise in hepatitis cases. Last year (2021) we started to see this in April, or summer, in covid positive children who were part of follow-up. Most of them in fact had recovered from their covid,” said Sumit Rawat, Associate Professor, Microbiology, BMC, and one of the authors of the study.
“Hepatitis A and E are specific to certain villages or regions, B is present through the year and D is usually from a parent or from a blood transfusion. Last year, following the Delta wave we saw these cases from all over the state, defying the usual histories,” he added.
Another recent case study suggested a possible link between liver disease and COVID-19.
The study published in the Journal of Pediatric Gastroenterology and Nutrition observed a previously healthy three-year-old girl who developed acute liver failure a few weeks after recovering from a mild COVID infection.
Dr. Anna Peters, a pediatric gastroenterologist at the Cincinnati Children’s Hospital Medical Center and the lead author of the study said, “”The patient had liver biopsy findings and blood testing consistent with a type of autoimmune hepatitis which may have been triggered by COVID infection.”
“I think it’s important for physicians to be aware that this is a rare condition that may happen during or after COVID infection. It’s important to check liver tests in patients who aren’t improving as expected,” she added.
Beware a global economy with little fires everywhere – The Guardian
Team leader critical of RCMP mental health support after Nova Scotia mass shooting
Alberta premier visits U.S. capital to talk North American energy security
Silver investment demand jumped 12% in 2019
Europe kicks off vaccination programs | All media content | DW | 27.12.2020 – Deutsche Welle
News8 hours ago
519 shares Online Dating Safety tips for the LGBTQ2S+ community
Tech3 hours ago
tvOS 15.5, watchOS 8.6, and HomePod Software 15.5 now available to the public – 9to5Mac
News2 hours ago
B.C. to launch ‘circle of care’ for neurodiverse kids but parents have many questions
News2 hours ago
Resilient infrastructure, faster disaster recovery needed to adapt to climate change
Economy12 hours ago
US Recession Risk, Wheat Watch, Chinese Economy Jolt: Eco Day – Bloomberg
Investment22 hours ago
Art8 hours ago
BlackburnNews.com – Blyth Festival Art Gallery reopens – BlackburnNews.com
Business22 hours ago
gas prices reach new high | CTV News – CTV News Toronto